ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GC38954-1mg |
|
852982-42-4 |
Tyroserleutide hydrochloride
|
0 | C18H28ClN3O6 | |
GC38953-50mg |
|
15790-94-0 |
trans-2-Undecenoic acid
|
0 | C11H20O2 | |
GC38953-10mg |
|
15790-94-0 |
trans-2-Undecenoic acid
|
0 | C11H20O2 | |
GC38952-10mg |
|
279215-43-9 |
Tifenazoxide
|
0 | C9H10ClN3O2S2 | |
GC38952-5mg |
|
279215-43-9 |
Tifenazoxide
|
0 | C9H10ClN3O2S2 | |
GC38951-100mg |
|
552-22-7 |
Thymol iodide
|
0 | C20H24I2O2 | |
GC38950-10mg |
|
92-35-3 |
Thiochrome
|
0 | C12H14N4OS | |
GC38950-5mg |
|
92-35-3 |
Thiochrome
|
0 | C12H14N4OS | |
GC38949-10mg |
|
2097509-36-7 |
Thalidomide-NH-PEG2-C2-NH2 TFA
|
0 | C21H25F3N4O8 | |
GC38949-5mg |
|
2097509-36-7 |
Thalidomide-NH-PEG2-C2-NH2 TFA
|
0 | C21H25F3N4O8 | |
GC38949-1mg |
|
2097509-36-7 |
Thalidomide-NH-PEG2-C2-NH2 TFA
|
0 | C21H25F3N4O8 | |
GC38948-5mg |
|
512784-93-9 |
SRX246
|
0 | C42H49N5O5 | |
GC38948-50mg |
|
512784-93-9 |
SRX246
|
0 | C42H49N5O5 | |
GC38948-10mg |
|
512784-93-9 |
SRX246
|
0 | C42H49N5O5 | |
GC38948-100mg |
|
512784-93-9 |
SRX246
|
0 | C42H49N5O5 | |
GC38947-50mg |
|
— |
SPR741 acetate
|
0 | C46H77N13O15 | |
GC38947-10mg |
|
— |
SPR741 acetate
|
0 | C46H77N13O15 | |
GC38947-5mg |
|
— |
SPR741 acetate
|
0 | C46H77N13O15 | |
GC38946-5mg |
|
— |
Secretin (28-54), human TFA
|
0 | C132H221N44F3O42 | |
GC38946-1mg |
|
— |
Secretin (28-54), human TFA
|
0 | C132H221N44F3O42 | |